UK Parliament / Open data

Breast Cancer Drugs

Proceeding contribution from Desmond Swayne (Conservative) in the House of Commons on Thursday, 26 January 2017. It occurred during Backbench debate on Breast Cancer Drugs.

There is an all-party group for almost every disease known to man, with the possible exception of rigor mortis. If patients and campaigners are to have confidence in clinical decision makers, there will have to be profound changes. At the moment, people lobby their MPs, who are uniquely unqualified to make these decisions. May I suggest to my hon. Friend that one of the changes might need to involve a thorough review of the framework and guidance under which the National Institute for Health and Care Excellence operates?

Type
Proceeding contribution
Reference
620 c529 
Session
2016-17
Chamber / Committee
House of Commons chamber
Back to top